Cargando…
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532241/ https://www.ncbi.nlm.nih.gov/pubmed/35871086 http://dx.doi.org/10.1038/s41409-022-01759-7 |
_version_ | 1784802077079240704 |
---|---|
author | Koenecke, Christian Eikema, Dirk-Jan Hazelaar, Sheree Schroeder, Thomas Potter, Victoria Kröger, Nicolaus Bornhäuser, Martin Finke, Jürgen Platzbecker, Uwe Radujkovic, Aleksandar Ganser, Arnold Salmenniem, Urpu Blaise, Didier Kobbe, Guido Meijer, Ellen Friis, Lone Maertens, Johan Caballero, Dolores Cornelissen, Jan J. Olivieri, Attilio Gulsum, Ozet Hayden, Patrick J. Onida, Francesco Robin, Marie Yakoub-Agha, Ibrahim |
author_facet | Koenecke, Christian Eikema, Dirk-Jan Hazelaar, Sheree Schroeder, Thomas Potter, Victoria Kröger, Nicolaus Bornhäuser, Martin Finke, Jürgen Platzbecker, Uwe Radujkovic, Aleksandar Ganser, Arnold Salmenniem, Urpu Blaise, Didier Kobbe, Guido Meijer, Ellen Friis, Lone Maertens, Johan Caballero, Dolores Cornelissen, Jan J. Olivieri, Attilio Gulsum, Ozet Hayden, Patrick J. Onida, Francesco Robin, Marie Yakoub-Agha, Ibrahim |
author_sort | Koenecke, Christian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9532241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95322412022-10-06 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT Koenecke, Christian Eikema, Dirk-Jan Hazelaar, Sheree Schroeder, Thomas Potter, Victoria Kröger, Nicolaus Bornhäuser, Martin Finke, Jürgen Platzbecker, Uwe Radujkovic, Aleksandar Ganser, Arnold Salmenniem, Urpu Blaise, Didier Kobbe, Guido Meijer, Ellen Friis, Lone Maertens, Johan Caballero, Dolores Cornelissen, Jan J. Olivieri, Attilio Gulsum, Ozet Hayden, Patrick J. Onida, Francesco Robin, Marie Yakoub-Agha, Ibrahim Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-07-23 2022 /pmc/articles/PMC9532241/ /pubmed/35871086 http://dx.doi.org/10.1038/s41409-022-01759-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Koenecke, Christian Eikema, Dirk-Jan Hazelaar, Sheree Schroeder, Thomas Potter, Victoria Kröger, Nicolaus Bornhäuser, Martin Finke, Jürgen Platzbecker, Uwe Radujkovic, Aleksandar Ganser, Arnold Salmenniem, Urpu Blaise, Didier Kobbe, Guido Meijer, Ellen Friis, Lone Maertens, Johan Caballero, Dolores Cornelissen, Jan J. Olivieri, Attilio Gulsum, Ozet Hayden, Patrick J. Onida, Francesco Robin, Marie Yakoub-Agha, Ibrahim Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title | Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title_full | Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title_fullStr | Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title_full_unstemmed | Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title_short | Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT |
title_sort | prognostic value of cpss cytogenetic risk classification in patients with cmml after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the chronic malignancies working party of the ebmt |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532241/ https://www.ncbi.nlm.nih.gov/pubmed/35871086 http://dx.doi.org/10.1038/s41409-022-01759-7 |
work_keys_str_mv | AT koeneckechristian prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT eikemadirkjan prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT hazelaarsheree prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT schroederthomas prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT pottervictoria prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT krogernicolaus prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT bornhausermartin prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT finkejurgen prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT platzbeckeruwe prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT radujkovicaleksandar prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT ganserarnold prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT salmenniemurpu prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT blaisedidier prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT kobbeguido prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT meijerellen prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT friislone prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT maertensjohan prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT caballerodolores prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT cornelissenjanj prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT olivieriattilio prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT gulsumozet prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT haydenpatrickj prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT onidafrancesco prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT robinmarie prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt AT yakoubaghaibrahim prognosticvalueofcpsscytogeneticriskclassificationinpatientswithcmmlafterallogeneichematopoieticcelltransplantationaretrospectivemulticenterstudyofthechronicmalignanciesworkingpartyoftheebmt |